SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-134294
Filing Date
2024-05-08
Accepted
2024-05-08 16:49:37
Documents
7
Effectiveness Date
2024-05-08

Document Format Files

Seq Description Document Type Size
1 S-8 d834326ds8.htm S-8 53710
2 EX-5.1 d834326dex51.htm EX-5.1 7063
3 EX-23.2 d834326dex232.htm EX-23.2 1595
4 EX-99.1(A) d834326dex991a.htm EX-99.1(A) 119696
5 EX-99.2(A) d834326dex992a.htm EX-99.2(A) 80775
6 EX-FILING FEES d834326dexfilingfees.htm EX-FILING FEES 19354
7 GRAPHIC g834326dsp9.jpg GRAPHIC 10786
  Complete submission text file 0001193125-24-134294.txt   298253
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279219 | Film No.: 24927074
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)